首页 | 本学科首页   官方微博 | 高级检索  
检索        

慢性乙型肝炎患者外周血IL-7与细胞免疫的关系
引用本文:童新灯,李敏,胡国信,熊晓佳,彭雁忠.慢性乙型肝炎患者外周血IL-7与细胞免疫的关系[J].中国热带医学,2014(8):912-914.
作者姓名:童新灯  李敏  胡国信  熊晓佳  彭雁忠
作者单位:北京大学深圳医院感染性疾病科,广东深圳518036
基金项目:深圳市科技研发资金项目(No.JCYJ20120616144140857)
摘    要:目的研究慢性乙型肝炎(CHB)患者外周血IL-7含量与T淋巴细胞亚群、调节性T细胞百分比的关系,探究IL-7对慢性乙型肝炎细胞免疫作用的影响。方法慢性乙型肝炎患者组、慢性乙型肝炎病毒(HBV)携带组、健康对照组,采用ELISA法检测受试者外周血IL-7含量,流式细胞仪技术检测外周血T淋巴细胞亚群和CD4+CD25+调节性T细胞百分比。结果 CHB组、HBV携带组、健康对照组外周血IL-7含量分别为(1.68±0.58)ng/mL、(3.83±0.62)ng/mL和(6.25±0.32)ng/mL,3组间存在显著性差异(P0.05);CHB组、HBV携带组、健康对照组外周血T细胞亚群CD4+T淋巴细胞分别为(31.3±3.3)%、(38.1±6.8)%、(43.2±9.4)%,CD8+T淋巴细胞分别为(24.8±5.2)%、(28.1±3.4)%、(30.5±8.6)%;CD4+CD25+调节性T细胞分别为(10.9±1.3)%、(7.4±1.0)%、(4.2±1.1)%。CHB组外周血IL-7明显低于HBV携带组及健康对照组,且与CD4+T细胞百分比呈负相关(r1=-0.58,P0.05),与CD8+T细胞百分比呈正相关(r2=0.63,P0.05),与CD4+CD25+调节性T细胞百分比呈负相关(r3=-0.43,P0.05)。结论 CHB患者外周血IL-7负调控调节性T细胞,对CD8+T细胞的细胞免疫有促进作用。

关 键 词:乙型肝炎病毒  白细胞介素7  调节性T细胞  T淋巴细胞亚群

Relationship between concentration of IL-7 and cellular immunity in peripheral blood of the patients with chronic hepatitis B
TONG Xin-deng,LI Min,HU Guo-xin,XIONG Xiao-jia,PENG Yan-zhong.Relationship between concentration of IL-7 and cellular immunity in peripheral blood of the patients with chronic hepatitis B[J].China Tropical Medicine,2014(8):912-914.
Authors:TONG Xin-deng  LI Min  HU Guo-xin  XIONG Xiao-jia  PENG Yan-zhong
Institution:(Department of Infectious Diseases, Shenzhen Hospital of Peking University, Shenzhen, 518036,Guangdong, P.R.China)
Abstract:Objective To study the relationship of the concentration of IL-7 with the percentage of T lymphocyte subsets and regulatory T cells in peripheral blood of the patients with chronic hepatitis B and explore the effects of IL-7 on cellular immune function. Methods The 48 patients were divided into CHB group (30 cases) and HBV carrier group (18 cases). In addition, there was a health control group(14 cases).The concentration of IL-7 in the peripheral blood in the chronic hepatitis B group , the chronic hepatitis B virus (HBV) carrier group, and the healthy control group were measured by ELISA and the percentage of T lymphocyte subsets and CD4+CD25+ regulatory T cells were detected by the flow cytometry. Results The concentration of IL-7 was (1.68 ± 0.58) ng/ml in the CHB group, (3.83 ± 0.62) ng/ml in HBV carriers group and (6.25 ± 0.32) ng/mL in the healthy control group, there were significant differences among the 3 groups (P〈0.05). The percentage of CD4+T cells in the CHB group, the HBV carriers group, and the healthy control group were (31.3 ± 3.3) %, (38.1 ± 6.8)% and (43.2 ± 9.4)%, respectively; CD8+T cells were (24.8 ± 5.2)%, (28.1 ± 3.4)% and (30.5 ± 8.6)% ,respectively; CD4+CD25+ regulatory T cells were (10.9 ± 1.3)%, (7.4 ± 1.0)% and (4.2 ± 1.1)% ,respectively. The concentration of IL-7 of the CHB group was significantly lower than that of HBV carrier group or healthy control group, it was negatively correlated with the percentage of CD4+T cells (r1=-0.58, P〈0.05) and CD4+CD25+ regulate T cells (r3=- 0.43, P〈0.05). However, it is positively correlated with the percentage of CD8+T cells (r2=0.63, P〈0.05). Conclusion IL-7 regulates negatively of regulatory T cells, and promotes the CD8+T cellular immunity of the patients with chronic hepatitis B.
Keywords:Hepatitis B virus  Interleukin 7  Regulatory T cells  T lymphocyte subsets
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号